Urology Doctors in Salisbury, NC Accepting Medicare

9 Urology doctors found. Showing 1 - 9

Dr. Wayne Allen Cline Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 911 W Henderson St, Ste 110, Salisbury, NC 28144 Phone: 704-633-9441

Peter Joseph Domenig, DO Urology Medicare: Medicare Enrolled Practice Location: 911 W Henderson St Ste 110, Salisbury, NC 28144 Phone: 704-633-9441    Fax: 704-637-9006

Atlee Rollins Johnson Iii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 911 W Henderson St, Ste 110, Salisbury, NC 28144 Phone: 704-633-9441

Vance F Merhoff, MD Urology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 911 W Henderson St, Ste 110, Salisbury, NC 28144 Phone: 704-633-9441    Fax: 704-637-9006

Robert Alvin Bertram, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 911 W Henderson St, Ste 110, Salisbury, NC 28144 Phone: 704-633-9441    Fax: 704-637-9006

Jason Richard Greenlee, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 911 W Henderson St Ste 110, Salisbury, NC 28144 Phone: 704-633-9441    Fax: 704-637-9006

Mrs. Cortney Julian Eller, FNP Urology Medicare: Accepting Medicare Assignments Practice Location: 611 Mocksville Ave, Salisbury, NC 28144 Phone: 704-633-7220    Fax: 704-647-0515

Jigishkumar Bipinchandra Vyas, MD Urology Medicare: Medicare Enrolled Practice Location: 1601 Brenner Ave, Salisbury, NC 28144 Phone: 800-706-9126

Dr. Robert Gene Moore, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 911 W Henderson St Ste 110, Salisbury, NC 28144 Phone: 704-633-9441    Fax: 704-637-9006

News Archive

Pevion announces further data from clinical study of PEV7 therapeutic Candida vaccine

Pevion Biotech AG today announced further data from the ongoing clinical study of its therapeutic Candida vaccine PEV7, demonstrating the generation of specific and functional B cell memory in 100% of vaccinees. Furthermore, the results again confirm the capability of Pevion's second generation virosomal vaccine platform to induce strong and long-lasting immunity in humans against otherwise weak antigens .

New light-based method to capture the epicenter of neural activity in the brain

Researchers from Istituto Italiano di Tecnologia and University of Salento, both in Lecce, Italy, and Harvard Medical School in Boston have developed a new light-based method to capture and pinpoint the epicenter of neural activity in the brain.

Factors associated with successful vaginal birth after Caesarean

Melissa Lunsford wants a vaginal delivery for her fourth child. Following a series of Caesarean and vaginal deliveries for her other children, she couldn't find a doctor or a hospital willing to give her the vaginal birth option for her current pregnancy.

Siemens' SARS-CoV-2 antibody immunoassays meet regulatory targets

New research being presented at the ESCMID Conference on Coronavirus Disease (ECCVID, online 23-25 September) shows that, in a head-to-head comparison of five tests used to detect SARS-CoV-2 antibodies (known as 'immunoassays'), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results.

pSivida's licensee submits NDA to FDA for Iluvien

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a New Drug Application to the U.S. Food and Drug Administration for Iluvien for Diabetic Macular Edema.

Read more Medical News

› Verified 9 days ago